| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 2.5K | 4.2% | 2.8% |
| Total Income | 2.5K | 4.2% | 2.8% |
| Expenditure | 2.0K | 4.0% | 1.9% |
| PBT | 557.30 | 25.1% | 23.6% |
| Net Profit | 466.50 | 26.5% | 20.1% |
| OPM | — | ||
| NPM | 18.41% | 5.59pp | 2.65pp |
| EPS | 3.18 | 26.6% | 19.1% |
Biogen Inc. Reports Q3 2025 Results
04 May 2026 · 4 May, 8:24 am
Summary
Biogen Inc. issued a press release announcing its results of operations and financial condition for the third quarter ended September 30, 2025. The press release was furnished as an exhibit to a Current Report on Form 8-K.
Informational and educational content only. Not investment advice.